Abstract
Seven patients with cardiovascular disease had clinical episodes and marked transaminase elevations that suggested viral hepatitis, but all had morphologic evidence (from liver biopsy or autopsy specimens) that documented centrilobular necrosis (ischemic hepatitis) with no evidence of viral or drug injury. Several also had moderate or marked passive congestion of the liver so the liver biopsies of 15 additional patients were retrospectively reviewed. In this latter group congestion alone was associated with normal or minimal elevation in transaminases while all patients with notable (>5 times normal) transaminase elevations had centrilobular necrosis. Congestion alone, no matter how severe or prolonged, seems to do little if any damage to the liver. Centrilobular necrosis, or ischemic hepatitis, correlates with significant hypertransaminasemia, appears to result from failure of hepatic perfusion (with or without preceding hypotension), and presents with clinical and laboratory manifestations that suggest viral hepatitis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Das G, Nussbaum HE, Leff WA: Hepatic function in acute myocardial infarction. JAMA 230:1558–1560, 1974
Nunes G, Blaisdell FW, Margaretten W: Mechanism of hepatic dysfunction following shock and trauma. Arch Surg 100:546–566, 1970
Ellenberg M, Osserman KE: The role of shock in the production of central liver cell necrosis. Am J Med 2:170–178, 1951
Clarke WTW: Centrilobular hepatic necrosis following cardiac infarction. Am J Pathol 26:249–255, 1949
Rich AR: The pathogenesis of the forms of jaundice. Bull Johns Hopkins Hosp 47:38–377, 1930
Seeley TT, Blumenfeld DM, Ikeda R, Knapp W, Ruebner BH: Hepatic infarction. Hum Pathol 3:265–276, 1972
Cohen JA, Kaplan MM: Left-sided heart failure presenting as hepatitis. Gastroenterology 74:583–587, 1978
Bloth B, deFaire U, Edhag O: Extreme elevation of transaminase levels in acute heart disease—A problem in differential diagnosis? Acta Med Scand 200:281–288, 1976
Bolton C, Barnard WG: The pathological occurrences in the liver in experimental venous stagnation. J Pathol Bacteriol 34:701–709, 1931
Kershner D, Hooton TC, Feinberg WG: Chemical studies on experimental hepatic congestion in the dog. Arch Surg 57:24–44, 1948
Simonds JP, Jergesen FH: Late changes in the liver induced by mechanical obstruction of the hepatic veins. Arch Pathol 20:571, 1935
Sherlock S: The liver in circulatory failure. Diseases of the Liver, 4th edition. L Schiff (ed). Philadelphia, Lippincott, 1975, pp 1033–1050
White TJ, Wallace RB, Gnassi AM, Kemp NF, Price P, Leevy CM: Hepatic anbormalities in congestive heart failure: Needle biopsy studies. Circulation 3:501–507, 1951
Sherlock S: Diseases of the Liver and Biliary System, 5th edition. Blackwell, London, 1975
Tisdale WA, LaMont JT, Isselbacher KJ:In Harrison's Principles of Internal Medicine, 7th edition, McGraw-Hill, 1974, p 1546
Levinsky RA, Lewis RM, Bynum TE, Hanley HG: Digoxin induced intestinal vasoconstriction. Circulation 52:130, 1975
Bynum TE, Hanley HG, Cole JS: Effect of digitalis glycosides on splanchnic blood flow in man. Clin Res 21:509, 1973
Bynum TE, Jacobson ED: Shock, intestinal ischemia and digitalis. Circulatory Shock 2:235, 1975
Kisloff B, Schaffer G: Fulminant hepatic failure secondary to congestive heart failure. Am J Dig Dis 21:895–900, 1975
Author information
Authors and Affiliations
Additional information
This study was supported, in part, by a grant from the James R. Dougherty, Jr. Foundation, Beeville, Texas.
Rights and permissions
About this article
Cite this article
Bynum, T.E., Boitnott, J.K. & Maddrey, W.C. Ischemic hepatitis. Digest Dis Sci 24, 129–135 (1979). https://doi.org/10.1007/BF01324740
Issue Date:
DOI: https://doi.org/10.1007/BF01324740